Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia characterized by telangiectases and arteriovenous malformations. These lesions cause bleeding, particularly in the nose, gastrointestinal tract and brain. HHT has incomplete penetrance, variable expressivity and genetic heterogeneity. De novo mutations associated with the onset of sporadic HHT have been reported. This Utility Gene Test was prepared on the basis of an analysis of the literature and existing diagnostic protocols. It is useful for confirming diagnosis, as well as for differential diagnosis, couple risk assessment and access to clinical trials.

Details

Title
Genetic testing for hereditary hemorrhagic telangiectasia
Author
Rakhmanov, Yeltay 1 ; Maltese, Paolo Enrico 1 ; Paolacci, Stefano 2 ; Marinelli, Carla 1 ; Mattassi, Raul Ettore 3 ; Amato, Bruno 4 ; Beccari, Tommaso 5 ; Dundar, Munis 6 ; Bertelli, Matteo 7 

 MAGI’s Lab, Rovereto, Italy 
 MAGI Euregio, Bolzano, Italy 
 Center for Vascular Malformations, “Stefan Belov”, Clinical Institute Humanitas “Mater Domini”, Castellanza (Varese), Italy 
 Department of Clinical Medicine and Surgery at University of Naples Federico II, Naples, Italy 
 Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy 
 Department of Medical Genetics, Erciyes University Medical School, Kayseri, Turkey 
 MAGI’s Lab, Rovereto, Italy; MAGI Euregio, Bolzano, Italy 
Pages
32-34
Publication year
2018
Publication date
2018
Publisher
De Gruyter Brill Sp. z o.o., Paradigm Publishing Services
e-ISSN
2564615X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3156324988
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.